CAR-T Cells: As the largest class in adoptive cell therapy, CAR-T cells are being engineered for greater precision, reduced toxicity, and durable anti-tumor responses. Advancements aim to address ...
Gilead Sciences' cell therapy Kite Pharma has bulked up its position in natural killer (NK) cell therapies, pledging up to $2.3 billion for a partnership with Shoreline Bioscience focusing on off ...
mast cells, monocytes and macrophages, neutrophils and NK cells. In this paper, a CRISPR-based gene addition strategy at the CX3CR1 locus of human hematopoietic stem cells is proposed to ...
Nov. 26, 2024 — Scientists have shed new light on how certain biological processes determine the development of neural cells. Their findings on a molecular 'bridge' complex demonstrate a new ...
Sections were examined under an Olympus BX61 fluorescence microscope (Olympus) and images captured with 10× and 20× magnifications ... but only a minor fraction (<1%) of those cell types showed ...
Nov. 27, 2024 — The food additive carrageenan (E 407) can be responsible for the development of chronic inflammatory bowel disease, ulcers, and increased blood sugar levels in animals ...
Using its proprietary iPSC product platform, the Company has established a leadership position in creating multiplexed-engineered master iPSC lines and in the manufacture and clinical development of ...